Involvement of the endocannabinoid system in drug addiction.
about
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so farAlcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorClinical correlates of co-occurring cannabis and tobacco use: a systematic reviewThe biological control of voluntary exercise, spontaneous physical activity and daily energy expenditure in relation to obesity: human and rodent perspectivesReduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticityThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinThe endocannabinoid system as an emerging target of pharmacotherapyGlutamatergic substrates of drug addiction and alcoholism[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptorTo Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-MakingBrain regional differences in CB1 receptor adaptation and regulation of transcriptionThe genetics of substance dependenceIndividual differences in response to positive and negative stimuli: endocannabinoid-based insight on approach and avoidance behaviorsDifferences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmissionGenetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypothesesNew treatments for cocaine dependence: a focused reviewThe role of CB1 receptors in psychostimulant addictionInhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addictionGenetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.Alterations of monetary reward and punishment processing in chronic cannabis users: an FMRI studyMarijuana Use Is Associated with Behavioral Approach and Depressive Symptoms in Adolescents and Emerging AdultsObesity: Current and potential pharmacotherapeutics and targets.ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure.Decreased reward sensitivity in rats from the Fischer344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signalingEndocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice.Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlatesCocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.The neurobiology of individual differences in complex behavioral traits.The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceAmygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression.The incentive salience of alcohol: translating the effects of genetic variant in CNR1.Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in micePharmacological approaches to methamphetamine dependence: a focused review.Interrelationship of CB1R and OBR pathways in regulation of metabolic, neuroendocrine, and behavioral responses to food restriction and voluntary wheel running.The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala.Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?
P2860
Q21090468-B91F2DF2-E6CB-49EA-B8F8-965888260DD2Q22241964-96B96967-247C-4DFE-805A-0C38F6C55BEEQ24602357-F922457D-1DEA-4AEE-A9E0-DE37DED0D59DQ24622846-C3403E96-C022-420E-95EB-9902BB01944BQ24642505-C212DA79-31E1-44F9-AD2B-1F78AEDA624DQ24643876-DBFCC2F3-D67D-494B-BDC9-4D5C6912C0BAQ24648473-6B7D96E4-7149-4185-BA89-7E73817B827DQ24648924-E4B59E76-9F0F-48D1-8EF9-5D148013BFFFQ24680848-6905DA11-1B74-47DA-8618-1CA9D840E177Q26770739-E9BA3F45-6085-4F58-9F07-EF3B58C52AA8Q26866100-DFAC3BD1-8A9C-47F9-8D66-B265E44DF61EQ27002251-0017A1DD-4523-447C-8C1F-AD99488AB9F0Q27023237-3C3F694A-E1DF-4773-A78B-DE9C9ED480C7Q27307029-AE427DF0-6EDE-40A2-958D-F6DA6FFC64A8Q27315226-69DA9576-092B-4F0F-9797-255C1C4E6508Q27324505-5E51A163-4EBC-4B4A-97F5-5D1EEF93B702Q28252765-391C88B0-5021-49C1-8582-C8E2DB7278C5Q28280265-641F76D8-016A-4F0C-825A-BBDA4B0E041FQ28283718-391A25DF-99B2-43FC-B075-E3305A2DC9BFQ28469322-80D75B10-2DBC-4C87-991E-05F87B843782Q28544894-160CF5ED-4CA2-467A-BAA4-B16CA749858CQ28553485-C2A3482E-CDE8-4E72-8EC4-D5AAEBBC2485Q30243992-B8F576CE-9EC3-4349-88CE-97B714709DDBQ30429221-E187C63F-5174-4A29-848D-FB49190F6ED2Q30470474-C7C196C3-EF91-42BC-9BD7-DE1675E3C4F2Q30473707-8D13AAAD-3A98-402B-AF9D-EAE047F29409Q30500429-EBB62481-DB1D-4D26-A5A6-5C9658CD2D6DQ30516052-F712E8B9-FEAE-4FBE-9567-F208498F9679Q30573498-24446114-90F4-4D32-9F21-211F69F397C7Q30630783-AFA67628-ECC1-4C65-9E90-95729C259982Q33435975-5B518FEA-A667-4110-A11F-7A128153B25FQ33703839-FEF1692C-E234-4DDC-AD36-251B95FE6C74Q33738017-C570E29B-8FF2-4909-9448-6B91028368E9Q33797978-D01087C0-C77D-429C-A947-56BD99FD5F1CQ33804240-D86FC36C-4837-4657-BC05-4D7580C2FB95Q33906303-52708A18-AD51-45AA-B797-53DB1DFD827DQ33912949-4BF0DD00-90D4-454C-8D05-DFA4DFBE8CEEQ33998480-CCAECD62-C2C8-4E04-8032-0986845D6B3DQ34012381-5A649EE0-A79F-4A09-B8C6-684416516238Q34098179-BFBA4644-3669-47A3-A55A-CBBD7086ACD4
P2860
Involvement of the endocannabinoid system in drug addiction.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Involvement of the endocannabinoid system in drug addiction.
@ast
Involvement of the endocannabinoid system in drug addiction.
@en
Involvement of the endocannabinoid system in drug addiction.
@nl
type
label
Involvement of the endocannabinoid system in drug addiction.
@ast
Involvement of the endocannabinoid system in drug addiction.
@en
Involvement of the endocannabinoid system in drug addiction.
@nl
prefLabel
Involvement of the endocannabinoid system in drug addiction.
@ast
Involvement of the endocannabinoid system in drug addiction.
@en
Involvement of the endocannabinoid system in drug addiction.
@nl
P2093
P1476
Involvement of the endocannabinoid system in drug addiction.
@en
P2093
Fernando Berrendero
Olga Valverde
Rafael Maldonado
P304
P356
10.1016/J.TINS.2006.01.008
P577
2006-02-17T00:00:00Z